Form Type: 4

SEC EDGAR Link
Accession Number:0001567619-20-012487
Date:2020-06-18
Issuer: GRITSTONE ONCOLOGY, INC. (GRTS)
Original Submission Date:

Reporting Person:

KROGNES STEVE E.
C/O GRITSTONE ONCOLOGY, INC.
5959 HORTON STREET, SUITE 300 EMERYVILLE, CA 94608

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 6.66 2020-06-18 deemed execution date A 12,500 (a) 2030-06-18 common stock 12,500 $6.66 12,500 direct
Footnotes
IDfootnote
f1 the option will vest and become exercisable on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date.
WhaleWisdom Logo

Elevate your investments